• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

Regulatory

Actions of government agencies regulating the pharmaceutical industry: approval, rejection, and prohibition of drugs, granting special statuses.

vaccines
Posted inCOVID-19, Infections, New Drugs, Regulatory

Pfizer and Moderna Release Booster Vaccines to Protect Against Omicron

September 1, 2022September 20, 2022

Updated bivalent mRNA vaccines Comirnaty and Spikevax target Omicron subvariants BA.4 and BA.5.

multiple-myeloma
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory

Tecvayli: New Drug for Multiple Myeloma

August 24, 2022September 8, 2022

Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.

Paxlovid (nirmatrelvir + ritonavir)
Posted inCOVID-19, Infections, Regulatory

Paxlovid for COVID-19 Treatment. All Details

August 24, 2022November 28, 2022

Paxlovid: treatment efficacy, “Paxlovid mouth”, COVID-19 rebound, management of Omicron variant, treatment resistance, generics, mechanism of action, price.

major-depressive-disorder
Posted inNeuroscience, New Drugs, Regulatory

Auvelity: New Antidepressant for Most Severe Depression

August 19, 2022September 8, 2022

Dextromethorphan and bupropion: A powerful drug combination that will help with depression that cannot be treated with standard antidepressants.

vaccine
Posted inCOVID-19, Infections, New Drugs, Regulatory

First Omicron Vaccine Appears

August 15, 2022September 8, 2022

Spikevax bivalent Original / Omicron (elasomeran + imelasomeran; mRNA-1273.214) by Moderna is the world’s first vaccine to protect against the Omicron variant of the SARS-CoV-2 coronavirus.

alopecia areata
Posted inAutoimmune Diseases, Clinical Trials, In the Pipeline, New Drugs, Regulatory

Alopecia Areata Treatment: What Future Holds

August 3, 2022September 8, 2022

What new drugs for hair loss are being developed by the pharmaceutical industry?

psoriasis
Posted inAutoimmune Diseases, New Drugs, Regulatory

Zoryve: New Effective Cream for Psoriasis

August 1, 2022September 8, 2022

Roflumilast will cure plaque psoriasis in half of patients.

Posts navigation

Newer posts 1 2 3 4 … 12 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News